{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:25:48Z","timestamp":1770726348317,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Taishan Scholars Program of Shandong Province"},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81701238"],"award-info":[{"award-number":["81701238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"20 policy supported projects of collaborative innovation and achievement transformation in universities and research institutes of Jinan","award":["2019GXRC050"],"award-info":[{"award-number":["2019GXRC050"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2020QH167"],"award-info":[{"award-number":["ZR2020QH167"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovative Research Project of Undergraduate Clinical Medicine Teaching of Qilu Hospital, Shandong University","award":["2019QLJY13"],"award-info":[{"award-number":["2019QLJY13"]}]},{"name":"Qingdao Technology Program for Health and Welfare","award":["20-3-4-42-nsh"],"award-info":[{"award-number":["20-3-4-42-nsh"]}]},{"name":"Qingdao Applied Basic Research Source Innovation Plan","award":["19-6-2-78-cg"],"award-info":[{"award-number":["19-6-2-78-cg"]}]},{"name":"Qingdao Key Health Discipline Development Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00415-021-10621-7","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T17:02:40Z","timestamp":1621616560000},"page":"280-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Anti-HMGCR myopathy overlaps with dermatomyositis-like rash: a distinct subtype of idiopathic inflammatory myopathy"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-4928","authenticated-orcid":false,"given":"Ying","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1563-5722","authenticated-orcid":false,"given":"Kai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingjun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8992-1866","authenticated-orcid":false,"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-5184","authenticated-orcid":false,"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"10","key":"10621_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","volume":"15","author":"L Musset","year":"2016","unstructured":"Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, Garcia-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovsky J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M (2016) Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmun Rev 15(10):983\u2013993. https:\/\/doi.org\/10.1016\/j.autrev.2016.07.023","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10621_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/art.30156","volume":"63","author":"AL Mammen","year":"2011","unstructured":"Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA (2011) Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 63(3):713\u2013721. https:\/\/doi.org\/10.1002\/art.30156","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10621_CR3","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62(9):2757\u20132766. https:\/\/doi.org\/10.1002\/art.27572","journal-title":"Arthritis Rheum"},{"key":"10621_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000416","author":"Y Watanabe","year":"2015","unstructured":"Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I (2015) Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Medicine (Baltimore). https:\/\/doi.org\/10.1097\/MD.0000000000000416","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10621_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nan.12380","volume":"43","author":"Y Allenbach","year":"2017","unstructured":"Allenbach Y, Benveniste O, Goebel HH, Stenzel W (2017) Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol 43(1):62\u201381. https:\/\/doi.org\/10.1111\/nan.12380","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"10621_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/BOR.0000000000000548","volume":"30","author":"A Ghirardello","year":"2018","unstructured":"Ghirardello A, Doria A (2018) New insights in myositis-specific autoantibodies. Curr Opin Rheumatol 30(6):614\u2013622. https:\/\/doi.org\/10.1097\/BOR.0000000000000548","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10621_CR7","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohme A, Charuel JL, Musset L, Allenbach Y, Benveniste O (2018) Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol 75(12):1528\u20131537. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2598","journal-title":"JAMA Neurol"},{"issue":"9","key":"10621_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O'Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Araguas E, Milisenda JC, Grau-Junyent JM, Mammen AL (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17(9):816\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"issue":"4","key":"10621_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL (2018) Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 20(4):21. https:\/\/doi.org\/10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"10621_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","volume":"14","author":"JE Hoogendijk","year":"2004","unstructured":"Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden The Netherlands. Neuromuscul Disord 14(5):337\u2013345. https:\/\/doi.org\/10.1016\/j.nmd.2004.02.006","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10621_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Working I-M, G, (2018) 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord 28(1):87\u201399. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.016","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10621_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mus.24541","volume":"52","author":"V Limaye","year":"2015","unstructured":"Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S (2015) Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve 52(2):196\u2013203. https:\/\/doi.org\/10.1002\/mus.24541","journal-title":"Muscle Nerve"},{"issue":"3","key":"10621_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","volume":"87","author":"A Hida","year":"2016","unstructured":"Hida A, Yamashita T, Hosono Y, Inoue M, Kaida K, Kadoya M, Miwa Y, Yajima N, Maezawa R, Arai S, Kurasawa K, Ito K, Shimada H, Iwanami T, Sonoo M, Hatanaka Y, Murayama S, Uchibori A, Chiba A, Aizawa H, Momoo T, Nakae Y, Sakurai Y, Shiio Y, Hashida H, Yoshizawa T, Sakiyama Y, Oda A, Inoue K, Takeuchi S, Iwata NK, Date H, Masuda N, Mikata T, Motoyoshi Y, Uesaka Y, Maeda MH, Nakashima R, Tsuji S, Kwak S, Mimori T, Shimizu J (2016) Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study. Neurology 87(3):299\u2013308. https:\/\/doi.org\/10.1212\/WNL.0000000000002863","journal-title":"Neurology"},{"issue":"10","key":"10621_CR14","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","volume":"87","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I (2016) Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. J Neurol Neurosurg Psychiatry 87(10):1038\u20131044. https:\/\/doi.org\/10.1136\/jnnp-2016-313166","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10621_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141616","author":"Y Ge","year":"2015","unstructured":"Ge Y, Lu X, Peng Q, Shu X, Wang G (2015) Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme a reductase antibodies in Chinese patients with idiopathic inflammatory myopathies. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0141616","journal-title":"PLoS ONE"},{"key":"10621_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jocn.2018.08.010","volume":"57","author":"Y Jiao","year":"2018","unstructured":"Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J (2018) Statin-naive anti-HMGCR antibody-mediated necrotizing myopathy in China. J Clin Neurosci 57:13\u201319. https:\/\/doi.org\/10.1016\/j.jocn.2018.08.010","journal-title":"J Clin Neurosci"},{"key":"10621_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000124","author":"A Alshehri","year":"2015","unstructured":"Alshehri A, Choksi R, Bucelli R, Pestronk A (2015) Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000124","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10621_CR18","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000290","author":"M Kadoya","year":"2016","unstructured":"Kadoya M, Hida A, Hashimoto Maeda M, Taira K, Ikenaga C, Uchio N, Kubota A, Kaida K, Miwa Y, Kurasawa K, Shimada H, Sonoo M, Chiba A, Shiio Y, Uesaka Y, Sakurai Y, Izumi T, Inoue M, Kwak S, Tsuji S, Shimizu J (2016) Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000290","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10621_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.24642","volume":"52","author":"T Chung","year":"2015","unstructured":"Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL (2015) The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve 52(2):189\u2013195. https:\/\/doi.org\/10.1002\/mus.24642","journal-title":"Muscle Nerve"},{"key":"10621_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2019.1672782","author":"R Aggarwal","year":"2019","unstructured":"Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV (2019) Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level. Scand J Rheumatol. https:\/\/doi.org\/10.1080\/03009742.2019.1672782","journal-title":"Scand J Rheumatol"},{"key":"10621_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/405956","author":"L Musset","year":"2014","unstructured":"Musset L, Miyara M, Benveniste O, Charuel JL, Shikhman A, Boyer O, Fowler R, Mammen A, Phillips J, Mahler M (2014) Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies. J Immunol Res. https:\/\/doi.org\/10.1155\/2014\/405956","journal-title":"J Immunol Res"},{"issue":"9","key":"10621_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","volume":"72","author":"CD Kassardjian","year":"2015","unstructured":"Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M (2015) Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol 72(9):996\u20131003. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1207","journal-title":"JAMA Neurol"},{"issue":"1","key":"10621_CR23","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1186\/ar4468","volume":"16","author":"L Drouot","year":"2014","unstructured":"Drouot L, Allenbach Y, Jouen F, Charuel JL, Martinet J, Meyer A, Hinschberger O, Bader-Meunier B, Kone-Paut I, Campana-Salort E, Eymard B, Tournadre A, Musset L, Sibilia J, Marie I, Benveniste O, Boyer O, French Myositis N (2014) Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. Arthritis Res Ther 16(1):R39. https:\/\/doi.org\/10.1186\/ar4468","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10621_CR24","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.autrev.2016.09.005","volume":"15","author":"M Alvarado-Cardenas","year":"2016","unstructured":"Alvarado-Cardenas M, Marin-Sanchez A, Martinez MA, Martinez-Martinez L, Pinal-Fernandez I, Labrador-Horrillo M, Balada E, Mundet-Tuduri X, Gonzalez-Mera L, Casademont J, Acebes EM, Moreno PJ, Juarez C, Grau-Junyent JM, Pujol-Borrell R, Selva-O\u2019Callaghan A (2016) Statin-associated autoimmune myopathy: a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev 15(12):1161\u20131166. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.005","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10621_CR25","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project consortium TEr, The Juvenile Dermatomyositis Cohort Biomarker S, Repository (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10621_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W, Benveniste O, Group EtWS (2020) 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018. Neuromuscul Disord 30(1):70\u201392. https:\/\/doi.org\/10.1016\/j.nmd.2019.10.005","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"10621_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jneuroim.2014.07.006","volume":"274","author":"S Suzuki","year":"2014","unstructured":"Suzuki S, Yonekawa T, Kuwana M, Hayashi YK, Okazaki Y, Kawaguchi Y, Suzuki N, Nishino I (2014) Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies. J Neuroimmunol 274(1\u20132):202\u2013208. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.07.006","journal-title":"J Neuroimmunol"},{"key":"10621_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jocn.2019.04.002","volume":"65","author":"M Liu","year":"2019","unstructured":"Liu M, Hou Y, Dai T, Lv J, Li W, Zhao Y, Fang Q, Yan C (2019) The clinical and histopathological features of idiopathic inflammatory myopathies with asymmetric muscle involvement. J Clin Neurosci 65:46\u201353. https:\/\/doi.org\/10.1016\/j.jocn.2019.04.002","journal-title":"J Clin Neurosci"},{"issue":"Pt 8","key":"10621_CR29","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/brain\/aww054","volume":"139","author":"Y Allenbach","year":"2016","unstructured":"Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, Schoindre Y, Rigolet A, Gilardin L, Musset L, Charuel JL, Boyer O, Jouen F, Drouot L, Martinet J, Stojkovic T, Eymard B, Laforet P, Behin A, Salort-Campana E, Fain O, Meyer A, Schleinitz N, Mariampillai K, Grados A, Benveniste O (2016) High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain 139(Pt 8):2131\u20132135. https:\/\/doi.org\/10.1093\/brain\/aww054","journal-title":"Brain"},{"issue":"5","key":"10621_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/rheumatology\/kew470","volume":"56","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, Pinal-Fernandez I, Lloyd TE, Albayda J, Paik J, Werner JL, Parks CA, Casciola-Rosen L, Christopher-Stine L, Mammen AL (2017) More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Rheumatology (Oxford) 56(5):787\u2013794. https:\/\/doi.org\/10.1093\/rheumatology\/kew470","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10621_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ (2012) Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 78(9):665\u2013671. https:\/\/doi.org\/10.1212\/WNL.0b013e318248dec1 (discussion 669)","journal-title":"Neurology"},{"issue":"12","key":"10621_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091\u20131098. https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2","journal-title":"Lancet Neurol"},{"issue":"5","key":"10621_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/jnen\/nly017","volume":"77","author":"Y Hou","year":"2018","unstructured":"Hou Y, Luo YB, Dai T, Shao K, Li W, Zhao Y, Lu JQ, Yan C (2018) Revisiting pathological classification criteria for adult idiopathic inflammatory myopathies: in-depth analysis of muscle biopsies and correlation between pathological diagnosis and clinical manifestations. J Neuropathol Exp Neurol 77(5):395\u2013404. https:\/\/doi.org\/10.1093\/jnen\/nly017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"10621_CR34","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/rheumatology\/kev229","volume":"54","author":"M Klein","year":"2015","unstructured":"Klein M, Mann H, Plestilova L, Zamecnik J, Betteridge Z, McHugh N, Vencovsky J (2015) Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience. Rheumatology (Oxford) 54(11):2010\u20132014. https:\/\/doi.org\/10.1093\/rheumatology\/kev229","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10621_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MD.0000000000000028","volume":"93","author":"Y Allenbach","year":"2014","unstructured":"Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, Maisonobe T, Dubourg O, Behin A, Laforet P, Stojkovic T, Eymard B, Costedoat-Chalumeau N, Campana-Salort E, Tournadre A, Musset L, Bader-Meunier B, Kone-Paut I, Sibilia J, Servais L, Fain O, Larroche C, Diot E, Terrier B, De Paz R, Dossier A, Menard D, Morati C, Roux M, Ferrer X, Martinet J, Besnard S, Bellance R, Cacoub P, Arnaud L, Grosbois B, Herson S, Boyer O, Benveniste O, French Myositis N (2014) Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 93(3):150\u2013157. https:\/\/doi.org\/10.1097\/MD.0000000000000028","journal-title":"Medicine (Baltimore)"},{"issue":"1\u20132","key":"10621_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1515\/znc-2003-1-211","volume":"58","author":"J Alarcon","year":"2003","unstructured":"Alarcon J, Aguila S, Arancibia-Avila P, Fuentes O, Zamorano-Ponce E, Hernandez M (2003) Production and purification of statins from Pleurotus ostreatus (Basidiomycetes) strains. Z Naturforsch C J Biosci 58(1\u20132):62\u201364. https:\/\/doi.org\/10.1515\/znc-2003-1-211","journal-title":"Z Naturforsch C J Biosci"},{"issue":"12","key":"10621_CR37","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1002\/art.34673","volume":"64","author":"JL Werner","year":"2012","unstructured":"Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL (2012) Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum 64(12):4087\u20134093. https:\/\/doi.org\/10.1002\/art.34673","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10621_CR38","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL, Shaham B, Weiss PF, Horkayne-Szakaly I, Targoff IN, Miller FW, Mammen AL, Childhood Myositis Heterogeneity Study G (2017) Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res (Hoboken) 69(7):1088\u20131094. https:\/\/doi.org\/10.1002\/acr.23113","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10621-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10621-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T17:11:27Z","timestamp":1641489087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10621-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10621"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10621-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Qilu Hospital (Qingdao), Shandong University, China (KYLL-qdql2020019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients or their guardian gave their written informed consent for participation in the study and further publications.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}